A study investigating effect of crizotinib and association between ALK rearrangements and clinical outcomes in primary lung adenocarcinoma patients from China
Phase of Trial: Phase IV
Latest Information Update: 09 Sep 2015
At a glance
- Drugs Crizotinib (Primary)
- Indications Adenocarcinoma; Lung disorders; Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.
- 21 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.